| Authors: |
Yauk CL; Department of Biology, University of Ottawa, Ottawa, ON, Canada., Lynch AM; Genetics and Investigative Toxicology, GSK, Stevenage, United Kingdom., Dobrovolsky VN; National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Schuler M; Pfizer Research, Development and Medical, Groton, CT, USA., Smith-Roe SL; Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA., Fitzgerald D; Independent Researcher (formerly TwinStrand Biosciences), Seattle, WA, USA., Higgins J; Independent Researcher (formerly TwinStrand Biosciences), Seattle, WA, USA., Honarvar N; BASF SE, Ludwigshafen, Germany., Le Curieux F; European Chemicals Agency, Helsinki, Finland., Matsumura S; R&D, Safety Science Research, Kao Corporation, Kanagawa, Japan., Minocherhomji S; Eli Lilly and Company, Indianapolis, IN, USA., Recio L; ScitoVation, Durham, NC, USA., Salk JJ; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Sugiyama KI; Division of Genome Safety Science, National Institute of Health Sciences, Kanagawa, Japan., Suzuki T; Division of Genome Safety Science, National Institute of Health Sciences, Kanagawa, Japan., Wills JW; Genetics and Investigative Toxicology, GSK, Stevenage, United Kingdom., Marchetti F; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada. Electronic address: Francesco.marchetti@hc-sc.gc.ca. |
